TWIST1 and breast cancer: In a different example, TWIST has been shown to recruit DNMT3B to the estrogen receptor 1 (ESR1) promoter, resulting in DNAme and loss of ER expression, and the progression of breast cancers that are ER-negative and hormone-resistant (24).